Bodycad announced it has been awarded two key US patents for improving the accuracy, reproducibility and speed for 3D constructs via MRI and CT images in long and small bone orthopaedic applications. These patents are critical to the company’s proprietary approach to creating personalized orthopaedic restorations based on each patient’s distinct anatomy.
To create personalized orthopaedic restorations, the company harnesses the world’s first suite of orthopaedic CAD/CAM software. This technology, along with individual patient imagery, is critical to Bodycad’s Personalized Restoration Evaluation Process (PREP).
“We are pleased to have the United States Patent and Trademark Office award these important and innovative patents to our library of intellectual property,” stated Jean Robichaud, Founder and President of Bodycad. “These patents are further evidence of our technology’s remarkable accuracy which is essential when creating a personalized orthopaedic restoration.”
Bodycad currently has numerous additional patents pending as well as an extensive collection of existing industrial design patents, copyrights and trademarks.
Bodycad is developing personalized orthopaedic restorations to overcome the limitations of off-the-shelf, standardized implants. With its proprietary Personalized Restoration Evaluation Process (PREP), it enables surgeons to provide patient-specific solutions with a previously unavailable conformity to every patient’s distinct anatomy. This transformative approach will allow mainstream customization with the goal of optimizing fit, durability and comfort. The privately held company was founded in 2011 and is headquartered in Quebec City, Canada with offices in the United States. Investors include Beaudier, Inc. (Montreal, Canada). ROBIC is patent counsel to Bodycad.